Lupin acquires exclusive rights to develop, manufacture TTP inhalation products

By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable inhaled medicines to patients across the globe

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31prdp5
via IFTTT